Lorbriqua 100mg Tablet
By Lorbriqua
Rx
30 Tablet in a Boxes

Composition
Lorlatinib(100mg)

Manufacturer - Pfizer Ltd
The Capital, 1802, 18th Floor , Plot No. C-70, 'G' Block , Bandra Kurla Complex, Bandra East , Mumbai – 400051.

Expires on or after
August, 2025

liver
Lorbriqua 100mg Tablet is considered safe for use in patients with liver disease. It is not necessary to adjust the dose of the medication. However, it is important to note that the recommended dosage regimen has not been determined for individuals with moderate to severe liver impairment. It is advised to exercise caution and consult with a healthcare provider before taking Lorbriqua 100mg Tablet if you have moderate to severe liver issues.

kidney
Lorbriqua 100mg Tablet needs caution in patients with severe kidney disease. Dose adjustment may be necessary, consult your doctor. No dose adjustment is needed for mild or moderate renal impairment.

alcohol
Consult your doctor when consuming alcohol with Lorbriqua 100mg Tablet.

driving
It is not clear if Lorbriqua 100mg Tablet affects driving. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Lorbriqua 100mg Tablet may not be safe during pregnancy. Animal studies suggest possible harm to the baby. Your doctor will assess the risks and benefits before prescribing this medication. Always consult your doctor regarding its use during pregnancy.

breastfeeding
During breastfeeding, use Lorbriqua 100mg Tablet cautiously. It is advised to pause breastfeeding until the mother's treatment is finished and the drug is no longer present in her body.
Habit Forming | No |
Chemical Class | Phenylpropanoid derivatives |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹312000
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025